Long‐term benefits of single‐dose psilocybin in depressed patients with cancer Phase 2 trial single dose of psilocybin delivers two years of depression relief for cancer patients https://t.co/JrYsS4Z1ol
Long-term benefits of single-dose psilocybin in depressed patients with cancer.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jun 2025 – Aug 2025Where it's discussed
-
News130 articles
-
X / Twitter69 posts
-
Blogs9 articles
-
Bluesky2 posts
-
YouTube2 videos
-
Facebook2 posts
-
Reddit2 posts
AI synopsis
What people are saying
Overall, the digital discussions praise the study for revealing long-lasting relief from depression and anxiety with a single dose of psilocybin, with words like 'promising' and 'game-changing' illustrating excitement and perceived importance. The tone and context suggest both strong agreement and high perceived impact of the research, supported by mentions of specific results such as 'lasting 2 years' and 'robust antidepressive activity.'
Most discussions express strong support and positivity towards the findings, citing the promising effects of psilocybin and its potential to treat depression in cancer patients.
The discussions demonstrate high curiosity and enthusiasm, with many posts emphasizing the significance of the long-term benefits and innovative treatment approach.
While the majority mention the study and its results directly, some posts reflect personal opinions or questions, indicating a moderate level of deep engagement.
The posts highlight that the publication could be transformative for mental health treatment in oncology, with phrases like 'paradigm-changing' and 'significant' underscoring its potential influence.
Abstract in brief
- A phase 2 trial found that a single dose of psilocybin, combined with psychological support, is safe, feasible, and effective for reducing depression and anxiety in cancer patients, with benefits lasting up to 2 years.
- In the study, approximately half of the patients experienced significant and sustained reductions in depression, while around 43% saw similar improvements in anxiety.
- These results suggest that psilocybin could be a promising new treatment for depression and anxiety in cancer patients, potentially offering an alternative to traditional antidepressants, though more research is needed.]
Top posts
Most liked on X and BlueskyA paper published this week explores the lasting benefits of psychedelic-assisted therapy for depression in cancer patients. The study outlines antidepressive effects persisting 2 years after a 25mg psilocybin dose combined with psychotherapy. Article: https://t.co/XiFVR9Bgrs https://t.co/ZpyyZ6o2Eq
Long-term benefits of single-dose psilocybin in depressed patients with cancer https://t.co/CgFF4HydKe
https://t.co/bNkulzedWq
https://t.co/76XpDW5QDc https://t.co/4kgOObOrYT
Psilocybin in depressed cancer patients: 'robust antidepressive activity from a single 25 mg dose of psilocybin combined with psychotherapy and suggest a potentially paradigm-changing alternative to traditional antidepressants' benefit lasted 2 years https://t.co/RDsFsBX0Op
All mentions
Long-term Effects of Single-Dose Psilocybin on Cancer Patients
This video discusses the long-term benefits of single-dose psilocybin therapy for depressed patients with cancer. Explore how this treatment can influence mental well-being and improve overall quality of life.
Psilocybin Shows Promising Long-Term Effects for Cancer Patients
A landmark clinical trial reveals that a single 25mg dose of psilocybin combined with therapy provides significant depression relief in cancer patients, with benefits lasting up to two years. This groundbreaking study…
@bryan_johnson https://t.co/Pa0h52RTo0
Long‐term benefits of single‐dose psilocybin in depressed patients with cancer - Agrawal - 2025 - Cancer - Wiley Online Library https://t.co/MSNAvfzOPE
New research from @zekeemanuel.bsky.social (@pennmehp.bsky.social) out in @JournalCancer finds long-term benefits of single-dose psilocybin in depressed patients with cancer acsjournals.onlinelibrary.wiley.com/doi/10.1002/...
RT @Kevin_McKernan: https://t.co/76XpDW5QDc https://t.co/4kgOObOrYT
RT @Kevin_McKernan: https://t.co/76XpDW5QDc https://t.co/4kgOObOrYT
مطالعهای بسیار جدید: یک دوز ۲۵ میلیگرم سیلوسایبین همراه با رواندرمانی در بیماران مبتلا به افسردگی و سرطان، اثرات ضدافسردگی و ضداضطراب پایداری تا ۲ سال داشته! حدود ۵۳٫۶٪ کاهش افسردگی، ۵۰٪ بهبود ماندگار و ۴۶٪ کاهش اضطراب. https://t.co/o9M4KmoIiU
Long‐term benefits of single‐dose psilocybin in depressed patients with cancer - Agrawal - 2025 - Cancer - Wiley Online Library https://t.co/mqnbmoxRGM
RT @Kevin_McKernan: https://t.co/76XpDW5QDc https://t.co/4kgOObOrYT
https://t.co/76XpDW5QDc https://t.co/4kgOObOrYT
https://t.co/76XpDW5QDc https://t.co/ruTXPD3Nni
RT @BellevueDoc: Long‐term benefits of single‐dose psilocybin in depressed patients with cancer Phase 2 trial single dose of psilocybin…
RT @BellevueDoc: Long‐term benefits of single‐dose psilocybin in depressed patients with cancer Phase 2 trial single dose of psilocybin…
RT @BellevueDoc: Long‐term benefits of single‐dose psilocybin in depressed patients with cancer Phase 2 trial single dose of psilocybin…
RT @BellevueDoc: Long‐term benefits of single‐dose psilocybin in depressed patients with cancer Phase 2 trial single dose of psilocybin…
RT @BellevueDoc: Long‐term benefits of single‐dose psilocybin in depressed patients with cancer Phase 2 trial single dose of psilocybin…
RT @BellevueDoc: Long‐term benefits of single‐dose psilocybin in depressed patients with cancer Phase 2 trial single dose of psilocybin…
RT @BellevueDoc: Long‐term benefits of single‐dose psilocybin in depressed patients with cancer Phase 2 trial single dose of psilocybin…
RT @BellevueDoc: Long‐term benefits of single‐dose psilocybin in depressed patients with cancer Phase 2 trial single dose of psilocybin…
RT @BellevueDoc: Long‐term benefits of single‐dose psilocybin in depressed patients with cancer Phase 2 trial single dose of psilocybin…
RT @BellevueDoc: Long‐term benefits of single‐dose psilocybin in depressed patients with cancer Phase 2 trial single dose of psilocybin…
RT @BellevueDoc: Long‐term benefits of single‐dose psilocybin in depressed patients with cancer Phase 2 trial single dose of psilocybin…
RT @BellevueDoc: Long‐term benefits of single‐dose psilocybin in depressed patients with cancer Phase 2 trial single dose of psilocybin…
RT @BellevueDoc: Long‐term benefits of single‐dose psilocybin in depressed patients with cancer Phase 2 trial single dose of psilocybin…
RT @BellevueDoc: Long‐term benefits of single‐dose psilocybin in depressed patients with cancer Phase 2 trial single dose of psilocybin…
RT @BellevueDoc: Long‐term benefits of single‐dose psilocybin in depressed patients with cancer Phase 2 trial single dose of psilocybin…
RT @BellevueDoc: Long‐term benefits of single‐dose psilocybin in depressed patients with cancer Phase 2 trial single dose of psilocybin…
RT @BellevueDoc: Long‐term benefits of single‐dose psilocybin in depressed patients with cancer Phase 2 trial single dose of psilocybin…
RT @BellevueDoc: Long‐term benefits of single‐dose psilocybin in depressed patients with cancer Phase 2 trial single dose of psilocybin…
RT @BellevueDoc: Long‐term benefits of single‐dose psilocybin in depressed patients with cancer Phase 2 trial single dose of psilocybin…
RT @BellevueDoc: Long‐term benefits of single‐dose psilocybin in depressed patients with cancer Phase 2 trial single dose of psilocybin…
RT @BellevueDoc: Long‐term benefits of single‐dose psilocybin in depressed patients with cancer Phase 2 trial single dose of psilocybin…
RT @BellevueDoc: Long‐term benefits of single‐dose psilocybin in depressed patients with cancer Phase 2 trial single dose of psilocybin…
RT @BellevueDoc: Long‐term benefits of single‐dose psilocybin in depressed patients with cancer Phase 2 trial single dose of psilocybin…
RT @BellevueDoc: Long‐term benefits of single‐dose psilocybin in depressed patients with cancer Phase 2 trial single dose of psilocybin…
RT @BellevueDoc: Long‐term benefits of single‐dose psilocybin in depressed patients with cancer Phase 2 trial single dose of psilocybin…
Long‐term benefits of single‐dose psilocybin in depressed patients with cancer Phase 2 trial single dose of psilocybin delivers two years of depression relief for cancer patients https://t.co/JrYsS4Z1ol
New research from @ZekeEmanuel (@PennMEHP) out in @JournalCancer finds long-term benefits of single-dose psilocybin in depressed patients with cancer https://t.co/QkIGtGQ1RW https://t.co/h7KTHMka9a
Long‐term benefits of single‐dose psilocybin in depressed patients with cancer - Agrawal - 2025 - Cancer - Wiley Online Library https://t.co/bnPbs32oaW
RT @SunstoneHeals: We’re pleased to announce the publication of our Long-term Benefits of Single-Dose Psilocybin in Depressed Patients with…
RT @BeckleyResearch: A paper published this week explores the lasting benefits of psychedelic-assisted therapy for depression in cancer pat…
RT @BeckleyResearch: A paper published this week explores the lasting benefits of psychedelic-assisted therapy for depression in cancer pat…
RT @BeckleyResearch: A paper published this week explores the lasting benefits of psychedelic-assisted therapy for depression in cancer pat…
RT @BeckleyResearch: A paper published this week explores the lasting benefits of psychedelic-assisted therapy for depression in cancer pat…
RT @BeckleyResearch: A paper published this week explores the lasting benefits of psychedelic-assisted therapy for depression in cancer pat…
RT @BeckleyResearch: A paper published this week explores the lasting benefits of psychedelic-assisted therapy for depression in cancer pat…
RT @BeckleyResearch: A paper published this week explores the lasting benefits of psychedelic-assisted therapy for depression in cancer pat…
Full clinical trial: https://t.co/NmNPDQCPPD
RT @BeckleyResearch: A paper published this week explores the lasting benefits of psychedelic-assisted therapy for depression in cancer pat…
RT @BeckleyResearch: A paper published this week explores the lasting benefits of psychedelic-assisted therapy for depression in cancer pat…
A paper published this week explores the lasting benefits of psychedelic-assisted therapy for depression in cancer patients. The study outlines antidepressive effects persisting 2 years after a 25mg psilocybin dose combined with psychotherapy. Article: https://t.co/XiFVR9Bgrs https://t.co/ZpyyZ6o2Eq
Long‐term benefits of single‐dose psilocybin in depressed patients with cancer - Agrawal - 2025 - Cancer - Wiley Online Library https://t.co/rLivoWArTi
Psilocybin in depressed cancer patients: 'robust antidepressive activity from a single 25 mg dose of psilocybin combined with psychotherapy and suggest a potentially paradigm-changing alternative to traditional antidepressants' benefit lasted 2 years https://t.co/RDsFsBX0Op
RT @drrickbarnett: https://t.co/bNkulzedWq
RT @drrickbarnett: https://t.co/bNkulzedWq
RT @drrickbarnett: https://t.co/bNkulzedWq
https://t.co/bNkulzedWq
RT @JournalCancer: Can a psychedelic compound from mushrooms benefit people with cancer and major depression?
Long-term benefits of single-dose psilocybin in depressed patients with cancer #psychedelics https://t.co/54bvE892pV
RT @JournalCancer: Can a psychedelic compound from mushrooms benefit people with cancer and major depression?
@Medscape So the study of interest is this one, appearing in CANCER. (Note the final author and, if you have a chance, read the disclosures...). https://t.co/cSvZRvwUuC https://t.co/fcbiT3svZv
A single guided psilocybin session may offer over two years of depression and anxiety relief for people with cancer. According to a new phase 2 clinical trial published in CANCER called Long-term benefits of single-dose psilocybin in depressed patients with cancer, 28 cancer https://t.co/MM7soAh0u3
RT @SunstoneHeals: We’re pleased to announce the publication of our Long-term Benefits of Single-Dose Psilocybin in Depressed Patients with…
RT @PsychedVantage: Long-term benefits of single-dose psilocybin in depressed patients with cancer https://t.co/CgFF4HydKe
Long-term benefits of single-dose psilocybin in depressed patients with cancer acsjournals.onlinelibrary.wiley.com/doi/10.1002/...
Long-term benefits of single-dose psilocybin in depressed patients with cancer https://t.co/SwbdOhElaW
RT @PsychedVantage: Long-term benefits of single-dose psilocybin in depressed patients with cancer https://t.co/CgFF4HydKe
RT @PsychedVantage: Long-term benefits of single-dose psilocybin in depressed patients with cancer https://t.co/CgFF4HydKe
We’re pleased to announce the publication of our Long-term Benefits of Single-Dose Psilocybin in Depressed Patients with Cancer Study in @JournalCancer, the Journal of the American Cancer Society! Led by our CEO and Principal Investigator, Dr. Manish Agrawal, this study https://t.co/GiP3XDOHqy
Long-term benefits of single-dose psilocybin in depressed patients with cancer https://t.co/CgFF4HydKe
RT @JournalCancer: Can a psychedelic compound from mushrooms benefit people with cancer and major depression?
Can a psychedelic compound from mushrooms benefit people with cancer and major depression?